ChemicalBook >> CAS DataBase List >>LOVASTATIN-D9

LOVASTATIN-D9

CAS No.
1002346-03-3
Chemical Name:
LOVASTATIN-D9
Synonyms
LOVASTATIN-D9;Lovastatin-[D9] (Standard)
CBNumber:
CB7199437
Molecular Formula:
C24H36O5
Molecular Weight:
404.55
MDL Number:
MFCD08063460
MOL File:
Mol file
MSDS File:
SDS
Last updated:2025-08-21 11:10:20

LOVASTATIN-D9 Properties

solubility Chloroform: slightly soluble
Methanol: slightly soluble

LOVASTATIN-D9 price More Price(3)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 26461 Lovastatin-d9 ≥99%deuteratedforms(d1-d9) 1mg $303 2026-04-30 Buy
ChemScene CS-0255610 Lovastatin-d9 1mg $617 2026-06-04 Buy
ChemScene CS-0255610 Lovastatin-d9 5mg $1874 2026-06-04 Buy
Product number Packaging Price Buy
26461 1mg $303 Buy
CS-0255610 1mg $617 Buy
CS-0255610 5mg $1874 Buy

LOVASTATIN-D9 Chemical Properties, Uses, Production

Description

Lovastatin-d9 is intended for use as an internal standard for the quantification of lovastatin (Item No. 10010338) by GC- or LC-MS. Lovastatin is a fungal metabolite that has been found in A. terreus and an inhibitor of HMG-CoA reductase (Ki = 1.4 nM).1,2 It is also a prodrug form of the HMG-CoA reductase inhibitor lovastatin hydroxy acid (Item No. 10010339).2 Lovastatin (8 mg/kg per day) reduces plasma cholesterol levels in dogs. It suppresses TNF-induced NF-κB activation (IC50 = ~15 µM) and potentiates apoptosis in human myeloid leukemia cells.3 Lovastatin also increases cellular lipid peroxidation and decreases glutathione peroxidase 4 (GPX4) levels in cancer cells.4 Formulations containing lovastatin have been used in the treatment of hypercholesterolemia.WARNING This product is not for human or veterinary use.

References

[1] ENDO A. The discovery and development of HMG-CoA reductase inhibitors.[J]. Journal of Lipid Research, 1992, 33 11: 1569-1582.
[2] A W ALBERTS. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1980, 77 7: 3957-3961. DOI: 10.1073/pnas.77.7.3957
[3] KWANG SEOK AHN  Bharat B A  Gautam Sethi. Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathway[J]. Biochemical pharmacology, 2008, 75 4: Pages 907-913. DOI: 10.1016/j.bcp.2007.10.010
[4] VASANTHI S. VISWANATHAN. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway[J]. Nature, 2017, 547 7664: 453-457. DOI: 10.1038/nature23007

LOVASTATIN-D9 Preparation Products And Raw materials

Raw materials

Preparation Products

LOVASTATIN-D9 Suppliers

Global Suppliers ( 8)
Supplier Tel Email Country ProdList Advantage
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767 sales@chemegen.com China 11123 58
MedBioPharmaceutical Technology Inc 021-69568360 18916172912 order@med-bio.cn China 8137 58
Manhag Testing Technology Co., Ltd 400-818 0104 18918165978 yanyan.guo@bestown.net.cn China 7770 58
TargetMol 400-821-0310 15002144251 xuexiang.shao@tsbiochem.com China 29128 58
LOVASTATIN-D9 Lovastatin-[D9] (Standard) 1002346-03-3 C24H27O5D9